Advertisement
Screener

RENOVORX, INC. (RNXT) Form D

RENOVORX, INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2024-02-09: Federal exemption Rule 506(c); Types of securities offered Equity; Date of first sale 2024-01-26; Total offering amount $15,000,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2024-02-09Rule 506(c)Equity2024-01-26$15,000,000$6,111,695$8,888,30592

Similar stocks

Stock NameCountryMarket CapPE Ratio
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
Pulmonx Corp (LUNG)United States$0.082B-1.16
CVRx, Inc. (CVRX)United States$0.067B-2.62
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
DarioHealth Corp. (DRIO)$0.066B-1.39
LENSAR, Inc. (LNSR)United States$0.087B2.02
Microbot Medical Inc. (MBOT)$0.089B-7.97
TELA Bio, Inc. (TELA)United States$0.057B-0.82
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Spectral AI, Inc. (MDAI)United States$0.052B